Schweiz - Deutsch - Tierarzneimittel Kompendium der Schweiz (Institut für Veterinärpharmakologie und toxikologie)

boehringer ingelheim (schweiz) gmbh - feline rhinotracheitis virus (herpesvirus fhv), strain f2, live attenuated, feline calicivirus antigens (fcv), strains 431 and g1, inactivated, feline panleukopenia virus (fpv), strain pli iv, live attenuated, feline leukemia virus (felv) recombinant of canarypox virus, strain vcp97, live - lyophilisat und suspension zur herstellung einer injektionssuspension für katzen - praeparatio cryodesiccata: feline rhinotracheitis virus (herpesvirus fhv), strain f2, live attenuated ≥ 10^4.9 u., feline calicivirus antigens (fcv), strains 431 and g1, inactivated ≥ 2.0 u., feline panleukopenia virus (fpv), strain pli iv, live attenuated ≥ 10^3.5 u., saccharum, sorbitolum, dextranum 40, caseinum hydrolysatum, collagenum hydrolysatum, dikalii phosphas anhydricus, kalii dihydrogenophosphas, kalii hydroxidum, pro dosi. i) suspension 0.5 ml: feline leukemia virus (felv) recombinant of canarypox virus, strain vcp97, live ≥ 10^7.2 u., kalii chloridum, natrii chloridum, kalii dihydrogenophosphas, dinatrii phosphas dihydricus, magnesii chloridum hexahydricum, calcii chloridum dihydricum, aqua ad iniectabile, ad suspensionem pro dosi 0.5 ml. ii) suspension 1 ml: feline leukemia virus (felv) recombinant of canarypox virus, strain vcp97, live ≥ 10^7.2 u., kalii chloridum, natrii chloridum, kalii dihydrogenophosphas, dinatrii phosphas dihydricus, magnesii chloridum hexahydricum, calcii chloridum dihydricum, aqua ad iniectabile, ad suspensionem pro dosi 1 ml. - attenuierter lebendimpfstoff gegen felines rhinotracheitis- und panleukopenievirus und inaktivierter impfstoff gegen felines calicivirus und lebendimpfstoff des kanarienpockenvirus gegen felines leukämievirus bei katzen - impfstoffe

Europäische Union - Deutsch - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - attenuated feline rhinotracheitis herpesvirus (fhv f2 strain), inactivated feline calicivirosis antigens (fcv 431 and g1 strains), attenuated feline panleucopenia virus (pli iv), felv recombinant canarypox virus (vcp97), attenuated chlamydophila felis (905 strain) - immunologischen arzneimitteln für felidae, - katzen - active immunisation of cats aged 8 weeks and older:against feline viral rhinotracheitis to reduce clinical signs;against calicivirus infection to reduce clinical signs;against chlamydophila felis infection to reduce clinical signs;against feline panleucopenia to prevent mortality and clinical signs;against leukaemia to prevent persistent viraemia and clinical signs of the related disease. onsets of immunity are 1 week after primary vaccination course for rhinotracheitis, calicivirus, chlamydophila felis and panleucopenia components, and 2 weeks after primary vaccination course for feline leukaemia component. the duration of immunity is one year after the last re-vaccination for the chlamydiosis and feline leukaemia components, and one year after primary vaccination course and three years after the last re-vaccination for the rhinotracheitis, calicivirosis and panleucopenia components.

Europäische Union - Deutsch - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - attenuated feline rhinotracheitis herpesvirus (fhv f2 strain), inactivated feline calicivirosis antigens (fcv 431 and g1 strains), attenuated feline panleucopenia virus (pli iv), felv recombinant canarypox virus (vcp97) - immunologischen arzneimitteln für felidae, - katzen - active immunisation of cats aged 8 weeks and older:against feline viral rhinotracheitis to reduce clinical signs;against calicivirus infection to reduce clinical signs ;against feline panleucopenia to prevent mortality and clinical signs;against leukaemia to prevent persistent viraemia and clinical signs of the related disease. onsets of immunity are 1 week after primary vaccination course for rhinotracheitis, calicivirus and panleucopenia components, and 2 weeks after primary vaccination course for feline leukaemia component. the duration of immunity is one year after the last re-vaccination for the feline leukaemia component, and one year after primary vaccination course and three years after the last re-vaccination for the rhinotracheitis, calicivirosis and panleucopenia components.

Schweiz - Deutsch - Tierarzneimittel Kompendium der Schweiz (Institut für Veterinärpharmakologie und toxikologie)

boehringer ingelheim (schweiz) gmbh - feline leukemia virus (felv) recombinant of canarypox virus, strain vcp97, live - injektionssuspension für katzen - feline leukemia virus (felv) recombinant of canarypox virus, strain vcp97, live 10^7.2 - 10^8.4 u., kalii chloridum, natrii chloridum, kalii dihydrogenophosphas, dinatrii phosphas dihydricus, magnesii chloridum hexahydricum, calcii chloridum dihydricum, aqua ad iniectabile, ad suspensionem pro dosi. - lebendimpfstoff des kanarienpockenvirus gegen das feline leukämievirus bei katzen - impfstoffe

Europäische Union - Deutsch - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - attenuated feline rhinotracheitis herpesvirus (fhv f2 strain), inactivated feline calicivirosis antigens (fcv 431 and g1 strains), attenuated chlamydophila felis (905 strain), attenuated feline panleucopenia virus (pli iv) - immunologischen arzneimitteln für felidae, - katzen - active immunisation of cats aged eight weeks and older:• against feline viral rhinotracheitis to reduce clinical signs;• against calicivirus infection to reduce clinical signs;• against chlamydophila felis infection to reduce clinical signs;• against feline panleucopenia to prevent mortality and clinical signs. anfänge der immunität wurden eine woche nach der grundimmunisierung für rhinotracheitis, calicivirus, chlamydophila felis und panleukopenie nachgewiesen. the duration of immunity is one year after the last re-vaccination for the chlamydiosis component, and oneyear after primary vaccination and three years after the last re-vaccination for the rhinotracheitis, calicivirosis and panleucopenia components.

Europäische Union - Deutsch - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - attenuated feline panleucopenia virus (pli iv) - immunologischen arzneimitteln für felidae, - katzen - active immunisation of cats aged eight weeks and older:against feline viral rhinotracheitis to reduce clinical signs;against calicivirus infection to reduce clinical signs;against feline panleucopenia to prevent mortality and clinical signs. onset of immunity is one week after primary vaccination course the duration of immunity is one year after the primary vaccination course and three years after the last re-vaccination.

Schweiz - Deutsch - Tierarzneimittel Kompendium der Schweiz (Institut für Veterinärpharmakologie und toxikologie)

boehringer ingelheim (schweiz) gmbh - feline rhinotracheitis virus (herpesvirus fhv), strain f2, live attenuated, feline calicivirus antigens (fcv), strains 431 and g1, inactivated - lyophilisat und lösungsmittel zur herstellung eine injektionssuspension für katzen - praeparatio cryodesiccata: feline rhinotracheitis virus (herpesvirus fhv), strain f2, live attenuated 10^4.9 - 10^6.2 u., feline calicivirus antigens (fcv), strains 431 and g1, inactivated 2.0 - 3.3 u., saccharum, sorbitolum, dextranum 40, caseinum hydrolysatum, collagenum hydrolysatum, dikalii phosphas anhydricus, kalii dihydrogenophosphas, kalii hydroxidum, natrii chloridum, dinatrii phosphas, pro vitro, residui: gentamicinum. i) lösungsmittel 0.5 ml: aqua ad iniectabile, ad solutionem pro 0.5 ml. ii) lösungsmittel 1 ml: aqua ad iniectabile, ad solutionem pro 1 ml. - attenuierter lebendimpfstoff gegen felines rhinotracheitisvirus mit antigenen des inaktiverten felinen calicivirus bei katzen - impfstoffe

Schweiz - Deutsch - Tierarzneimittel Kompendium der Schweiz (Institut für Veterinärpharmakologie und toxikologie)

boehringer ingelheim (schweiz) gmbh - rabies recombinant of canary pox virus, strain vcp65, live - injektionssuspension für katzen - rabies recombinant of canary pox virus, strain vcp65, live 10^6.8 u., kalii chloridum, natrii chloridum, kalii dihydrogenophosphas, dinatrii phosphas dihydricus, magnesii chloridum hexahydricum, calcii chloridum dihydricum, aqua ad iniectabile, ad suspensionem pro dosi 1 ml. - lebendimpfstoff des kanarienpockenvirus gegen tollwut bei katzen - impfstoffe

Schweiz - Deutsch - Tierarzneimittel Kompendium der Schweiz (Institut für Veterinärpharmakologie und toxikologie)

boehringer ingelheim (schweiz) gmbh - feline rhinotracheitis virus (herpesvirus fhv), strain f2, live attenuated, feline calicivirus antigens (fcv), strains 431 and g1, inactivated, feline panleukopenia virus (fpv), strain pli iv, live attenuated, chlamydophila felis, strain 905, live attenuated - lyophilisat und lösungsmittel zur herstellung einer injektionssuspension für katzen - praeparatio cryodesiccata: feline rhinotracheitis virus (herpesvirus fhv), strain f2, live attenuated 10^4.9- 10^6.2 u., feline calicivirus antigens (fcv), strains 431 and g1, inactivated 2.0 - 3.3 u., feline panleukopenia virus (fpv), strain pli iv, live attenuated 10^3.5 - 10^5.2 u., chlamydophila felis, strain 905, live attenuated 10^3.0 - 10^5.0 u., saccharum, sorbitolum, dextranum 40, caseinum hydrolysatum, collagenum hydrolysatum, dikalii phosphas anhydricus, kalii dihydrogenophosphas, kalii hydroxidum, natrii chloridum, dinatrii phosphas, pro vitro, residui: gentamicinum. i) lösungsmittel 0.5 ml: aqua ad iniectabile, ad solutionem pro 0.5 ml. ii) lösungsmittel 1 ml: aqua ad iniectabile, ad solutionem pro 1 ml. - attenuierter lebendimpfstoff gegen felines rhinotracheitis- und panleukopenievirus mit antigegen des inakitivierten felinen calicivirus und bakterieller lebendimpfstoff gegen chlamydophila felis bei katzen - impfstoffe

Schweiz - Deutsch - Tierarzneimittel Kompendium der Schweiz (Institut für Veterinärpharmakologie und toxikologie)

boehringer ingelheim (schweiz) gmbh - feline rhinotracheitis virus (herpesvirus fhv), strain f2, live attenuated, feline calicivirus antigens (fcv), strains 431 and g1, inactivated, feline panleukopenia virus (fpv), strain pli iv, live attenuated - lyophilisat und lösungsmittel zur herstellung einer injektionssuspension für katzen - praeparatio cryodesiccata: feline rhinotracheitis virus (herpesvirus fhv), strain f2, live attenuated ≥ 10^4.9 u., feline calicivirus antigens (fcv), strains 431 and g1, inactivated ≥ 2.0 u., feline panleukopenia virus (fpv), strain pli iv, live attenuated ≥ 10^3.5 u., saccharum, sorbitolum, dextranum 40, caseinum hydrolysatum, collagenum hydrolysatum, dikalii phosphas anhydricus, kalii dihydrogenophosphas, kalii hydroxidum, pro dosi. i) lösungsmittel 0.5 ml: aqua ad iniectabile, ad solutionem pro dosi 0.5 ml. ii) lösungsmittel 1 ml: aqua ad iniectabile, ad solutionem pro dosi 1 ml. - attenuierter lebendimpfstoff gegen felines rhinotracheits- und panleukopenievirus mit antigenen des inaktiverten felinen calicivirus bei katzen - impfstoffe